382 related articles for article (PubMed ID: 19906009)
1. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.
Zhu S; Li W; Ward MF; Sama AE; Wang H
Inflamm Allergy Drug Targets; 2010 Mar; 9(1):60-72. PubMed ID: 19906009
[TBL] [Abstract][Full Text] [Related]
2. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
Bae JS
Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
[TBL] [Abstract][Full Text] [Related]
3. HMGB1 is a therapeutic target for sterile inflammation and infection.
Andersson U; Tracey KJ
Annu Rev Immunol; 2011; 29():139-62. PubMed ID: 21219181
[TBL] [Abstract][Full Text] [Related]
4. Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity.
Horiuchi T; Sakata N; Narumi Y; Kimura T; Hayashi T; Nagano K; Liu K; Nishibori M; Tsukita S; Yamada T; Katagiri H; Shirakawa R; Horiuchi H
J Biol Chem; 2017 May; 292(20):8436-8446. PubMed ID: 28373282
[TBL] [Abstract][Full Text] [Related]
5. Targeting Inflammation Driven by HMGB1.
Yang H; Wang H; Andersson U
Front Immunol; 2020; 11():484. PubMed ID: 32265930
[TBL] [Abstract][Full Text] [Related]
6. Role of HMGB1 in cardiovascular diseases.
Li W; Sama AE; Wang H
Curr Opin Pharmacol; 2006 Apr; 6(2):130-5. PubMed ID: 16487750
[TBL] [Abstract][Full Text] [Related]
7. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
Musumeci D; Roviello GN; Montesarchio D
Pharmacol Ther; 2014 Mar; 141(3):347-57. PubMed ID: 24220159
[TBL] [Abstract][Full Text] [Related]
8. High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target.
VanPatten S; Al-Abed Y
J Med Chem; 2018 Jun; 61(12):5093-5107. PubMed ID: 29268019
[TBL] [Abstract][Full Text] [Related]
9. Blockade of extracellular high-mobility group box 1 attenuates inflammation-mediated damage and haze grade in mice with corneal wounds.
Zhou Y; Wang T; Wang Y; Meng F; Ying M; Han R; Hao P; Wang L; Li X
Int Immunopharmacol; 2020 Jun; 83():106468. PubMed ID: 32279044
[TBL] [Abstract][Full Text] [Related]
10. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.
Wang H; Ward MF; Sama AE
Shock; 2009 Oct; 32(4):348-57. PubMed ID: 19333143
[TBL] [Abstract][Full Text] [Related]
11. Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain.
Agalave NM; Svensson CI
Mol Med; 2015 Feb; 20(1):569-78. PubMed ID: 25222915
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.
Andersson U; Yang H; Harris H
Semin Immunol; 2018 Aug; 38():40-48. PubMed ID: 29530410
[TBL] [Abstract][Full Text] [Related]
13. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.
Paudel YN; Angelopoulou E; Piperi C; Balasubramaniam VRMT; Othman I; Shaikh MF
Eur J Pharmacol; 2019 Sep; 858():172487. PubMed ID: 31229535
[TBL] [Abstract][Full Text] [Related]
14. HMGB1-directed drug discovery targeting cutaneous inflammatory dysregulation.
Lamore SD; Cabello CM; Wondrak GT
Curr Drug Metab; 2010 Mar; 11(3):250-65. PubMed ID: 20406187
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of HMGB1-targeting agents in sepsis.
Wang H; Zhu S; Zhou R; Li W; Sama AE
Expert Rev Mol Med; 2008 Nov; 10():e32. PubMed ID: 18980707
[TBL] [Abstract][Full Text] [Related]
16. High-Mobility Group Box 1-Induced Complement Activation Causes Sterile Inflammation.
Kim SY; Son M; Lee SE; Park IH; Kwak MS; Han M; Lee HS; Kim ES; Kim JY; Lee JE; Choi JE; Diamond B; Shin JS
Front Immunol; 2018; 9():705. PubMed ID: 29696019
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 as a potential therapeutic target.
Wang H; Li W; Goldstein R; Tracey KJ; Sama AE
Novartis Found Symp; 2007; 280():73-85; discussion 85-91, 160-4. PubMed ID: 17380789
[TBL] [Abstract][Full Text] [Related]
18. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.
Yang H; Hreggvidsdottir HS; Palmblad K; Wang H; Ochani M; Li J; Lu B; Chavan S; Rosas-Ballina M; Al-Abed Y; Akira S; Bierhaus A; Erlandsson-Harris H; Andersson U; Tracey KJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11942-7. PubMed ID: 20547845
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 release by inflammasomes.
Vande Walle L; Kanneganti TD; Lamkanfi M
Virulence; 2011; 2(2):162-5. PubMed ID: 21422809
[TBL] [Abstract][Full Text] [Related]
20. Targeting HMGB1 in the treatment of sepsis.
Wang H; Ward MF; Sama AE
Expert Opin Ther Targets; 2014 Mar; 18(3):257-68. PubMed ID: 24392842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
